12:00 AM
May 14, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

SL-701 cancer data

Researchers at the University of Pittsburgh reported data from 22 evaluable pediatric patients showing that subcutaneous SL-701 every 3 weeks produced 3 partial responses, 1 case of disease-free survival (DFS) following surgery and 14 cases of stable disease...

Read the full 168 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >